METASTATIC ESOPHAGEAL CANCER
Clinical trials for METASTATIC ESOPHAGEAL CANCER explained in plain language.
Never miss a new study
Get alerted when new METASTATIC ESOPHAGEAL CANCER trials appear
Sign up with your email to follow new studies for METASTATIC ESOPHAGEAL CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New Immune-Cell cocktail takes on tough gut cancers
Disease control OngoingThis phase 2 trial is testing a five-drug combination for people with advanced esophageal, stomach, or gastroesophageal junction cancer that has worsened after initial treatment. The combination includes immune cells from healthy donors, two immunotherapy drugs, and two standard …
Matched conditions: METASTATIC ESOPHAGEAL CANCER
Phase: PHASE2 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 12:34 UTC
-
Donor immune cells get a boost in new cancer trial
Disease control TerminatedThis early-phase study tests whether giving healthy donor NK cells along with two medicines (vactosertib and IL-2) is safe and helps the cells stay active in people with advanced colorectal, stomach, esophageal, or blood cancers. The NK cells are meant to attack cancer, but the b…
Matched conditions: METASTATIC ESOPHAGEAL CANCER
Phase: PHASE1 • Sponsor: David Wald • Aim: Disease control
Last updated Jun 27, 2026 07:57 UTC